Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Bibliographic Details
Main Authors: Rachel NeMoyer, Arindam Mondal, Mehul Vora, Elaine Langenfeld, Danea Glover, Michael Scott, Lauren Lairson, Christopher Rongo, David J. Augeri, Youyi Peng, Salma K. Jabbour, John Langenfeld
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cell Communication and Signaling
Online Access:http://link.springer.com/article/10.1186/s12964-019-0469-5

Internet

http://link.springer.com/article/10.1186/s12964-019-0469-5

Similar Items